1. Introduction {#sec1}
===============

Cardiovascular diseases remain the top cause of global mortality, with an estimated 17.9 million attributed deaths in 2016 (31% of global deaths).[@bib1] Hypertension is consistently related to the development of ischemic heart disease, heart failure, stroke, and chronic kidney disease; an estimated 57% and 24% of stroke and coronary artery disease-related deaths, respectively are due to hypertension.[@bib2], [@bib3], [@bib4], [@bib5] According to the global burden of diseases estimate 2015, it is the most important cause of mortality as well as the loss of disability-adjusted life years.[@bib6]

Since the early 1950s, there have been many studies in India reporting the prevalence of hypertension across various geographic, occupational, and linguistic groups.[@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13] Analysis of worldwide data for estimation of the global prevalence of hypertension in 2005 highlighted the lack of a national study investigating the prevalence in India.[@bib14] There is also heterogeneity among the present studies in the method of measuring blood pressure (BP) (mercury and aneroid or electronic machines), the definition of hypertension, and enrollment of participants.

This survey was conducted to estimate the prevalence of hypertension among Indian adults.

2. Materials and methods {#sec2}
========================

2.1. Study setting {#sec2.1}
------------------

The study was conducted as a part of Cardiac Prevent 2015---under the aegis of the Cardiological Society of India. On 21 September 2015, from 9am to 5pm, we measured the BP of consecutive adult participants (age ≥18 years) attending the BP camp across 24 states and union territories of India. All participants gave informed written consent.

2.2. Hypertension definition {#sec2.2}
----------------------------

Hypertension was defined according to the Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7).[@bib15]

2.3. Blood pressure measurement and data collection {#sec2.3}
---------------------------------------------------

BP was measured using automated oscillometric machines. Before measuring BP, the participant should not have taken tea or coffee in the last 10 min and should have been seated for at least 5 min. Individuals with BP reading ≥140/90 mmHg had their BP remeasured after 3 min; the average of the two BP measurements was recorded. The average BP was rounded off to the nearest whole number. We recorded a self-reported history of hypertension, diabetes, and use of antihypertensive medications. A printed report of BP measurement was provided to the patient. Individual site coordinators were responsible for data collection which was fed real-time into an online portal designed by the Cardiological Society of India. An independent auditor (not involved in data collection) reviewed and verified the number of participants from each site.

2.4. Statistical analysis {#sec2.4}
-------------------------

Total prevalence was age- and gender-standardized according to 2011 census population of India.[@bib16] Distribution of BP across the four classifications (normal, prehypertension, Stage I hypertension and Stage 2 hypertension) was calculated across six mutually exclusive age groups (18--19, 20--44, 45--54, 55--64, 65--74, and ≥ 75 years). Hypertension prevalence was also calculated according to the World Health Organization (WHO) world standard population for the year 2000--2025; as recommended by the World Hypertension League.[@bib17]^,^[@bib18] All analyses were performed using STATA V15.0 (College Station, TX, USA) statistical software.

3. Results {#sec3}
==========

Across 24 states and union territories of India a total of 180,335 participants \[120,425 (66.8%) men and 59,910 (33.2%) women\] with mean age 40.6 ± 14.9 years were surveyed. 8,898 (4.9%), 99,791 (55.3%), 35,694 (11.9%), 23,084 (12.8%), 9,989 (5.5%), and 2,878 (1.6%) subjects belonged to age group 18--19, 20--44, 45--54, 55--64, 65--74, and ≥ 75 years respectively. Prevalence of self-reported hypertension and diabetes was 15.9% and 10.1%, respectively.

Overall prevalence of hypertension was 30.7% (95% confidence interval \[CI\]: 29.7, 32.8). Prevalence increased with age; with more men having hypertension in each age group, except in those with age ≥65 years, where almost equal percentage of men and women had hypertension **(**[Table 1](#tbl1){ref-type="table"} and [Fig. 1](#fig1){ref-type="fig"}**)**. Prevalence adjusted for 2011 census population of India was 29.7%; prevalence adjusted for the WHO reference population was 32.8%.Table 1Prevalence of hypertension.Table 1Age (years)Men (*n* = 120,425)Women (*n* = 59,910)Total (*n* = 180,335)18--19 (n = 8,898)16.1 (15.1, 17.0)6.2 (5.4, 7.0)12.2 (11.5, 12.9)20--44 (n = 99,791)26.7 (26.4, 27.1)14 (13.6, 14.4)22.4 (22.2, 22.7)45--54 (n = 35,694)42.4 (41.8, 43)34.6 (33.7, 35.4)39.8 (39.4, 40.3)55--64 (n = 23,084)49.0 (48.2, 49.9)45.4 (44.2, 46.5)47.9 (47.2, 48.5)65--74 (n = 9,989)51.5 (50.3, 52.7)51.4 (49.6, 53.3)51.5 (50.5, 52.4)≥75 (n = 2,878)52.2 (50.1, 54.4)51.3 (47.8, 54.8)52.0 (50.2, 53.8)Total (n = 180,335)34.2 (33.9, 34.5)23.7 (23.3, 24.0)30.7 (30.5, 30.9)[^1]Fig. 1Prevalence of hypertension, according to age group and gender.Fig. 1

Both systolic BP (SBP) and diastolic BP (DBP) were higher among men than women across all age groups **(**[Fig. 1](#fig1){ref-type="fig"}). Mean SBP and DBP according to age group is given in [Table 2](#tbl2){ref-type="table"}. Mean SBP and DBP increased with increasing age in both genders till age 65 years after which it reached a plateau **(**[Fig. 2](#fig2){ref-type="fig"}A and B**)**.Table 2Mean systolic and diastolic blood pressure.Table 2MenWomenTotal**Age (years)**41.1 ± 15 (29--52)39.7 ± 14.7 (27--50)40.6 ± 14.9 (28--51)**Mean SBP (mmHg)** 18--19121.4 ± 15 (110--130)111.4 ± 12.4 (102--120)117.5 ± 14.9 (110--127) 20--44124.1 ± 15.1 (114--130)115.6 ± 15.0 (108--122)121.2 ± 15.6 (110--130) 45--54130.2 ± 18.2 (120--140)126.7 ± 18.0 (113--140)129.0 ± 18.2 (119--140) 55--64134.1 ± 19.5 (120--144)132.4 ± 19.3 (120--140)133.6 ± 19.5 (120--143) 65--74136.5 ± 20.4 (120--150)136.0 ± 21.2 (120--149.5)136.4 ± 20.7 (120--150) ≥75137.2 ± 21.4 (120--150)136.0 ± 22.7 (120--148)136.8 ± 21.8 (120--150) Total127.5 ± 17.5 (117--138)120.8 ± 18.2 (110--130)125.3 ± 18.0 (110--135)**Mean DBP (mmHg)** 18--1974.8 ± 11 (69--80)71.9 ± 9.6 (66--80)73.7 ± 10.6 (68--80) 20--4479.6 ± 10.9 (70--86)75.1 ± 10.4 (70--80)78.1 ± 10.9 (70--84) 45--5483.2 ± 11.7 (77--90)80.3 ± 10.9 (70--90)82.2 ± 11.5 (75--90) 55--6482.9 ± 11.6 (76--90)81.1 ± 11.0 (73--90)82.4 ± 11.4 (76--90) 65--7481.8 ± 11.9 (74--90)80.8 ± 11.9 (70--90)81.5 ± 11.9 (72--90) ≥7580.1 ± 12.4 (70--90)80.6 ± 12.9 (70--90)80.2 ± 12.5 (70--90) Total80.6 ± 11.4 (72--90)77.0 ± 11.0 (70--81)79.5 ± 11.4 (70--87)[^2][^3]Fig. 2A. Mean systolic blood pressure (SBP) across age groups. B. Mean diastolic blood pressure (DBP) across age groups.Fig. 2

Among those not on any antihypertensive medication, only 28.6% of participants were found to have normal BP. Most participants were in the prehypertension stage **(**[Table 3](#tbl3){ref-type="table"}**)**. 42.9% in the age group of 18--19 years had prehypertension.Table 3Characteristics of Indian adults by blood pressure categories.Table 3SBP/DBP categories among those not taking Anti-HTN medicationsTaking Anti-HTN Medication (*n* = 23,213)Normal BP\
\<120/\<80 mmHgPrehypertension\
120-139/80--89 mmHgStage 1 HTN\
140-159/90--99 mmHgStage 2 HTN ≥160/≥100 mmHgAge (years) 18--193,983 (45.0)3,797 (42.9)998 (11.3)73 (0.8)47 (0.2) 20--4431,018 (32.6)44,222 (46.5)18,290 (19.2)1,674 (1.8)4,587 (19.8) 45--546,021 (20.8)12,625 (43.7)8,744 (30.2)1,526 (5.3)6,778 (29.2) 55--642,689 (16.7)6,566 (40.7)5,461 (33.8)1,411 (8.8)6,957 (30.0) 65--74951 (15.2)2,454 (39.3)2,094 (33.6)740 (11.9)3,750 (16.2) ≥75307 (17.2)677 (44.8)584 (23.0)216 (3.6)3,750 (4.7)Men23,690 (22.6)49,291 (47.0)27,644 (26.3)4,358 (4.2)15,442 (66.5)Women21,280 (40.8)21,050 (40.4)8,527 (16.4)1,282 (2.5)7,771 (33.5)Total44,970 (28.6)70,341 (44.8)55,850 (23.0)5,640 (3.6)23,213 (12.9)[^4]

There were 12.9% (95% CI, 12.7--13.0) subjects on antihypertensive medications. Of total 55,370 participants with hypertension, 28,614 (51.4%) were aware of their disease status. Of those who were aware, 23,213 (81.1%) were on any antihypertensive medication. Of those on medication, only 13,545 (41.6%) had BP within the target (SBP\<140 mmHg and DBP\<90 mmHg).

4. Discussion {#sec4}
=============

We report a high prevalence of hypertension among Indian adults, with almost one in three participants having hypertension. There are around 762 million Indians ≥18 years of age in India,[@bib16] which means there are currently 234 million adults with hypertension.

A similar prevalence of 26.5% was reported by a study using health survey--based nationwide blood pressure data (*n* = 1,320,555).[@bib19] Data from the National Family Health Survey-4 (NFHS-4) (*n* = 802,927) suggest a much lower prevalence of 11.3%.[@bib20] This could be due to the overrepresentation of women (87.2% in NFHS-4 vs. 34.3% in our study) and a younger study population (15--49 years) in NFHS-4.[@bib20] Anchala *et al*[@bib21] reported a similar prevalence of 29.8% in their meta-analysis where they pooled results from 142 hypertension prevalence studies from 1950 to 2013, representing around 0.3 million subjects.

Trends from the noncommunicable disease (NCD) Risk factor Collaboration (NCD-RisC) suggest that from 1975 to 2015, the mean systolic and diastolic blood pressure, as well as the prevalence of hypertension in the Indian population, has remained stable.[@bib22] Studies included in this analysis varied in their methodology and population selection. This is the first time that the NFHS has collected data on noncommunicable diseases such as obesity and hypertension. In subsequent years, this data will help better understand the epidemiological trends.

We found a high prevalence of hypertension among young adults (20--44 years). The prevalence in this age group is more than twice the prevalence in a similar population in the United States (22.4% vs. 10.5%, respectively).[@bib23] This increased prevalence of hypertension and prehypertension among young Indians is being increasingly reported.[@bib24], [@bib25], [@bib26] This is a disturbing trend because it puts an increasing number of young Indians at an increased risk of premature mortality due to cardiovascular causes.[@bib27] Currently, Indians experience cardiovascular event--related deaths almost a decade earlier than developed countries, with cardiovascular events responsible for 52% of all deaths in those aged \<70 years in India, as compared with 23% in these countries.[@bib28]

The increasing trend in both systolic and diastolic BP till the fifth and the sixth decade followed by a decline in the diastolic BP observed in our study suggests that isolated systolic hypertension is the predominant form of hypertension in the elderly.[@bib29]^,^[@bib30]

We observed a higher proportion of participants who were aware, on treatment, and had controlled BP than was reported by Roy *et al* (51.0% vs. 38.7%, 88.0% vs. 32.3%, and 41.0% vs. 12.8% respectively).[@bib26] A probable reason could be that the population we surveyed was mostly working class and there could be a behavioral bias among those getting their BP measured, with those more educated, aware, and concerned about their health status attending the camp. The awareness of high blood pressure was, however, much lower than that reported in similar studies from Canada (83%), the USA (81%), or England (65%).[@bib31]

It is estimated that around 17.6% of patients with hypertension globally live in India, which suggests an expected large increase in cardiovascular diseases burden in the near future.[@bib26]^,^[@bib32]^,^[@bib33] This mandates early detection and treatment, as adequate BP control can avert almost a third of all cardiovascular-related mortality.[@bib34]

Homogenous data collection, real-time feeding of data in the online system, and independent review of all readings are the strengths of this study. For the first time, we report the genderwise prevalence of hypertension across age groups. There are, however, some limitations. The study may have a selection bias as the healthy volunteers usually turn up for checkups. However, the effect of this bias is likely to be small given the large sample size.

5. Conclusion {#sec5}
=============

There is a very high prevalence of hypertension among Indian adults, across all age groups. In addition, there is poor awareness, treatment, and control among those with hypertension.What is already known?•Regional prevalence of hypertension in specific geographical locations.What does this study add?•Age group and gender wise prevalence of hypertension through nationally representative data.•Prevalence standardized to the census population and WHO standard population.
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[^1]: Data as percentage (95% confidence interval).

[^2]: Data as mean ± standard deviation (25th to 75th percentile).

[^3]: SBP: systolic blood pressure; DBP: diastolic blood pressure.

[^4]: Data as *n* (percentage). SBP: systolic blood pressure; DBP: diastolic blood pressure; HTN: hypertension.
